NSD2 and prostate cancer: Studies have also shown overexpression of NSD2 in multifarious solid tumors, including lung cancer, prostate cancer, colorectal cancer, cervical cancer, breast cancer, and osteosarcoma.3, 4, 5, 6, 7, 8, 9, 10, 11